Trivitron Healthcare Africa (THA) is a joint venture between Trivitron Healthcare Group, India and Investment Funds for Health in Africa (IFHA). We aim to boost the healthcare ecosystem of the continent by providing advanced medical modalities and reliable health services. THA seeks to provide not just the most advanced medical devices but also dependable after-sales service across Africa so that medical equipment across the African continent become widely accessible and cost-effective, as well.
Headquartered in Dubai, the United Arab Emirates, Trivitron Healthcare Africa has a direct presence and sales and service infrastructure in Nairobi, Kenya; and Johannesburg, South Africa. The company plans to leverage these hubs to harness neighboring countries’ potential and manage a broad network of channel partners across Africa.
THA encompass a full range of laboratory medicine, medical imaging, critical care, operation theatre, and renal care products along with after-sales services. The company manufactures these high quality products in Trivitron’s U.S. FDA / CE-certified factories in India, Finland and Turkey. THA also provides engineering support and is involved in the distribution of products from other leading global corporations, as well.
For the execution of turnkey hospital projects in Africa, THA boasts an exclusive Products division that immensely contributes to the success of these undertakings. In addition, THA also offers a Multi-Vendor Biomedical Engineering Services division to provide maximum support for healthcare providers across Africa. Moreover, THA has also set up academic tie-ups with reputable academic institutions in India and Europe to offer paramedical and super-speciality support courses.
Since its founding in 1997, Trivitron strives to provide cost-effective, yet the best healthcare solutions. Marketing to hospitals, individual healthcare providers, independent clinics and laboratories, extended care facilities and all other entities providing healthcare solutions, Trivitron is a pioneer in its field. With years of experience in manufacturing and distributing affordable, innovative and accessible products, Trivitron is fully familiar with its target markets and technological updates. It is a leading medical technology company of Indian origin and its presence around the world is only growing stronger by the day with there already being more than 50,000 installations in 165 countries worldwide. With the Trivitron conglomerate powered by 1,500 employees in addition to 1,200 channel partners, networking across the globe in order to provide solutions to healthcare providers all over the world and ensure the company’s day-to-day operations aligns with the vision in a seamless process. Reliable 24x7 customer support complements the service offering to tackle any issues concerning operation and product installation.
The Investment Funds for Health in Africa (IFHA) was the first private equity fund dedicated to investing in small and medium-sized enterprises in the private healthcare sector in Africa when it was launched in 2008 in Amsterdam, Netherlands. Today, IFHA confidently boasts approximately $200 million of assets under management (AUM) with investments spanning the entire healthcare value chain in Sub-Saharan Africa. IFHA’s funds are backed by both public and private investors including the European Investment Bank and International Finance Corporation alongside the private insurer Achmea to name a few. Furthermore, the IFHA team has immensely talented professionals across all geographies with extensive knowledge, experience and relationships that help them invest in healthcare in Africa.
To be the largest, most respected and admired Medical Technology Company of Indian origin with a global presence promoting cost-effective medical technology products and services.
To innovate and provide Medical Technology Products, Services and Solutions to make healthcare affordable and accessible to everyone across the globe.